1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow Inapplicable: new trials by email Literature Review of Inapplicable trials Research Report on Inapplicable
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Assessing the Effect of DZD9008 on the Pharmacokinetics of the Cocktail Probes Representative for CYP3A4, P-gp, BCRP and OATP1B1 in Patients with EGFR or HER2 Mutant Advanced Non-small Cell Lung Cancer (WU-KONG19) DZD9008 and Probe drugs (midazolam, digoxin, rosuvastatin) - Non-small Cell Lung Cancer | Phase 1 | Completed | Dizal Pharmaceuticals | 25 | 2023-07-31 | 2024-12-13 |
Carcinoma, Non-Small-Cell Lung (1)
China (1)